Cardinal Health (CAH) has issued an update.
Cardinal Health, Inc. has reorganized its business structure to enhance efficiency and transparency, aligning its operations into new reporting segments: the Pharmaceutical and Specialty Solutions segment and the Global Medical Products and Distribution segment, alongside three smaller segments reported as Other. They’ve released recast financial results for fiscal years 2022, 2023, and the first half of 2024 to reflect this change, which doesn’t alter past financial statements but adjusts inter-segment revenue and corporate expense allocations. This new structure will be fully adopted in financial reporting starting in the third quarter of fiscal year 2024.
Learn more about CAH stock on TipRanks’ Stock Analysis page.
